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Résumé en
anglais
Microparticles are membrane vesicles with pro-inflammatory properties. Circulating
levels of microparticles have previously been found to be elevated in patients with
metabolic syndrome (MetS). The present study aimed to evaluate the effects of in
vivo treatment with microparticles, from patients with MetS and from healthy
subjects (HS), on ex vivo vascular function in mice. Microparticles isolated from
MetS patients or HS, or a vehicle were intravenously injected into mice, following
which vascular reactivity in response to vasoconstrictor agonists was assessed by
myography with respect to cyclo-oxygenase pathway, oxidative and nitrosative stress.
Injection of microparticles from MetS patients into mice induced vascular hypo-
reactivity in response to serotonin. Hypo-reactivity was associated with up-regulation
of inducible NO-synthase and increased production of NO, and was reversed by the
NO-synthase inhibitor (N(G)-nitro-L-arginine). The selective COX-2 inhibitor (NS398)
reduced the contractile effect of serotonin in aortas from mice treated with vehicle or
HS microparticles; however, this was not observed within mice treated with MetS
microparticles, probably due to the ability of MetS microparticles to enhance
prostacyclin. MetS microparticle-mediated vascular dysfunction was associated with
increased reactive oxygen species (ROS) and enhanced expression of the NADPH
oxidase subunits. Neutralization of the pro-inflammatory pathway Fas/FasL
completely prevented vascular hypo-reactivity and the ability of MetS microparticles
to enhance both inducible NO-synthase and monocyte chemoattractant protein-1
(MCP-1). Our data provide evidence that microparticles from MetS patients induce ex
vivo vascular dysfunction by increasing both ROS and NO release and by altering
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